The Form 144 is a routine advance notice of a small sale by a former officer. Given the minimal size relative to market cap and the insider's non-executive status, the filing is unlikely to have a material impact on the stock. Monitor for any subsequent Form 4 filings to confirm execution, but no immediate trading action is warranted.
Price Chart
Executive Summary
Zachary Prensky, a former officer of LB Pharmaceuticals, filed a Form 144 notice of intent to sell 16,500 shares of common stock, with an estimated aggregate market value of approximately $486,566. The sale is planned for June 9, 2026, via Stifel Nicolaus & Company. While the filing signals insider intent to sell, the relatively small size relative to the company's $843M market cap and the seller's status as a former officer reduce the signal's materiality.
Key Facts
- Insider Zachary Prensky (former officer) filed Form 144 to sell 16,500 shares.
- Estimated aggregate market value of the proposed sale: ~$486,566.
- Sale is planned for June 9, 2026, via Stifel Nicolaus & Company.
- Shares were acquired on September 12, 2025, and are held directly.
- The sale represents a small fraction of the company's $843M market cap.
Financial Impact
Proposed sale of ~$486,566 worth of shares, representing ~0.06% of market cap.
Risk Factors
- Insider sale could be perceived negatively if followed by additional insider selling.
- The filing is only an intent to sell; the actual sale may not occur.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001972481-26-000189 |
| Document: 0001972481-26-000189-index.html | 0001972481-26-000189 |
| Document: 0001972481-26-000189.txt | 0001972481-26-000189 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 13, 2026 13d ago | SC 13G/A | $34.79 | awaiting T+60 | — | $39.34 (+13.08%) |
Oct 6, 2026 20d ago | EFFECT | $34.26 | awaiting T+60 | — | $39.34 (−14.83%) |
Sep 15, 2026 5w ago | 8-K | $43.04 | awaiting T+60 | — | $39.34 (−8.60%) |
Sep 3, 2026 7w ago | 8-K | $47.52 | awaiting T+60 | — | $39.34 (−17.21%) |
Aug 11, 2026 10w ago | 8-K | $45.33 | awaiting T+60 | — | $39.34 (−13.21%) |
Aug 11, 2026 10w ago | Press Release | $45.33 | awaiting T+60 | — | $39.34 (−13.21%) |
Jul 29, 2026 12w ago | 8-K | $39.00 $39.42 | ▲ +1.08% | ▼ −3.65% | $39.34 (+0.87%) |
Jul 22, 2026 13w ago | 8-K | $35.84 $36.69 | ▲ +2.37% | ▼ −0.89% | $39.34 (+9.77%) |
Jul 22, 2026 13w ago | Press Release | $35.84 $36.69 | ▲ +2.37% | ▼ −0.89% | $39.34 (+9.77%) |
Jun 10, 2026 19w ago | 8-K | $28.54 | awaiting T+60 | — | $39.34 (+37.84%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers